Citation 67080

ERDELMEIER,CAJ: REGENASS,U: RALI,T: STICHER,O:. (1992). INDOLE ALKALOIDS WITH IN VITRO ANTIPROLIFERATIVE ACTIVITY FROM THE AMMONIACAL EXTRACT OF NAUCLEA ORIENTALIS.. 58(1)

Citation Details

TitleINDOLE ALKALOIDS WITH IN VITRO ANTIPROLIFERATIVE ACTIVITY FROM THE AMMONIACAL EXTRACT OF NAUCLEA ORIENTALIS.
AuthorsERDELMEIER,CAJ: REGENASS,U: RALI,T: STICHER,O:
Year1992
Volume58
Issue1

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (1)

Nauclea orientalis (RUBIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FOR
NoneNone
2
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
None
WEAK ACTIVITY
3
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
None
WEAK ACTIVITY
4Not specified
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
ANGUSTINE
None
5
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTINE
ACTIVE
6
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTINE
ACTIVE
7Not specified
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
ANGUSTINE,18-19-DIHYDRO:
None
8
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTINE,18-19-DIHYDRO:
WEAK ACTIVITY
9
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTINE,18-19-DIHYDRO:
ACTIVE
10Not specified
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
ANGUSTINE,3-14-DIHYDRO:
None
11
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTINE,3-14-DIHYDRO:
ACTIVE
12
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANGUSTINE,3-14-DIHYDRO:
ACTIVE
13Not specified
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
ANGUSTINE,3-14-18-19-TETRAHYDRO:
None
14
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTINE,3-14-18-19-TETRAHYDRO:
ACTIVE
15
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTINE,3-14-18-19-TETRAHYDRO:
ACTIVE
16Not specified
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
NAUCLEFINE
None
17
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NAUCLEFINE
ACTIVE
18
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NAUCLEFINE
ACTIVE
19Not specified
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
ANGUSTOLINE
None
20
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTOLINE
WEAK ACTIVITY
21
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTOLINE
ACTIVE
22Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANGUSTOLINE,3-14-DIHYDRO: ISOMER A
None
23
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTOLINE,3-14-DIHYDRO: ISOMER A
WEAK ACTIVITY
24
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTOLINE,3-14-DIHYDRO: ISOMER A
WEAK ACTIVITY
25Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANGUSTOLINE,3-14-DIHYDRO: ISOMER B
None
26
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTOLINE,3-14-DIHYDRO: ISOMER B
WEAK ACTIVITY
27
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTOLINE,3-14-DIHYDRO: ISOMER B
WEAK ACTIVITY
28Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANGUSTINE,10-HYDROXY:
None
29
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTINE,10-HYDROXY:
ACTIVE
30
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANGUSTINE,10-HYDROXY:
ACTIVE
Show SPARQL Queries (1)